Disease & Cancer Genetics
From understanding mutagenesis, pathogenicity, formation, real-time monitoring, epigenetics, the prevalence in certain cultures and impact, we’re extracting and managing vast amounts of data points that tie directly to predicting precursors of disease traits and proactively target disease behaviors.
While product development in the life science industry has been the same for years, the adoption of technologies for augmenting and speeding up the discovery process is becoming more essential. Dive into the data we’re configuring specifically for your organization to overcome internal barriers.
Virtual/Hybrid Clinical Trial Design
As much as 80%* of underrepresented patients are unaware of options to be included within a clinical trial geared toward a specific therapeutic indication. Designing ways to reach these patients requires a coordination effort from more than just apps and sensors, see how we design natural language and AI into a structure of a clinical trial to bring opportunities for inclusion in a virtual and hybrid setting.
Post Market Surveillance
Often overlooked, Phase IV trial adherence are essential to the long-term viability of the product. 20-30% of clinical trials are accurately represented with conducting and concluding Phase IV trials to inform public and private stakeholders for product efficacy. Use our data to drive a feedback loop to continue effective product development efforts.